Open Access
Rifampicin-induced thrombocytopenia
Author(s) -
Ajay Kumar Verma,
Arpita Singh,
Amol Chandra,
Santosh Kumar,
Rajesh Kumar Gupta
Publication year - 2010
Publication title -
indian journal of pharmacology/the indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/0253-7613.68432
Subject(s) - rifampicin , adverse effect , medicine , tuberculosis , drug , intensive care medicine , pharmacology , pathology
In the treatment of tuberculosis there are special therapeutic problems related to adverse effects of drugs, compliance to treatment, and microbial resistance. Thrombocytopenia is an uncommon but potentially fatal adverse effect of certain anti-tubercular drugs when the incriminating drug is taken by a susceptible individual. We report a case of rifampicin-induced thrombocytopenia, which although rare, needs attention.